Aion Therapeutic Inc. (ANTCF)
| Market Cap | 3.36M |
| Revenue (ttm) | 580.85K |
| Net Income (ttm) | -4.58M |
| Shares Out | n/a |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 11,125 |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | 0.0036 - 0.0400 |
| Beta | 0.55 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Dec 30, 2024 |
About Aion Therapeutic
Aion Therapeutic Inc. engages in the health and wellness business in the United States. The company was formerly known as Osoyoos Cannabis Inc. and changed its name to Aion Therapeutic Inc. in August 2020. Aion Therapeutic Inc. was incorporated in 2011 and is based in Vancouver, Canada. [Read more]
Full Company ProfileNews
Aion Therapeutic Provides Update on Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - December 6, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") provides an update on its previously announced private placement. Furthe...
Aion Therapeutic Announces Revocation of MCTO
Toronto, Ontario--(Newsfile Corp. - November 13, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has received an order from the British C...
Aion Therapeutic Provides Bi-Weekly MCTO Status Update
Toronto, Ontario--(Newsfile Corp. - October 24, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is providing this bi-weekly update on the status of its management cease...
Aion Therapeutic Hires CRO for Toppen Health; Announces Director Resignation
Toronto, Ontario--(Newsfile Corp. - October 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen" ...
Aion Therapeutic Announces Non- Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - October 21, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered privat...
Aion Therapeutic Announces Closing of First Tranche of Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has closed the first tranche (the "Firs...
Aion Therapeutic Announces Grant of Management Cease Trade Order
Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that further to its release issued on August 14, 2024 in ...
Aion Therapeutic Announces Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - August 23, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it intends to complete a non-brokered private...
Aion Therapeutic Reports Delay in Filing 2024 Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - August 14, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that the Company will be unable to file its annual audite...
Aion Therapeutic Secures Licensing Agreement for Molecular Iodine Technology
Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company"), through its water filtration subsidiary, Toppen Health, Inc. ("Toppen"), i...
Aion Therapeutic Completes Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - May 17, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has completed a non-brokered private placemen...
Aion Therapeutic Announces Proposed Non- Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - April 22, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it plans to complete a non-brokered private pl...
Aion Therapeutic Responds to First-Ever U.S. Drinking Water Standard Making PFAS Removal a Top Priority
Toronto, Ontario--(Newsfile Corp. - April 12, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") and its water filtration subsidiary, Toppen Health, Inc. ("Toppen" or "Top...
Aion Therapeutic Engages Independent Trading Group for Market Making Services
Toronto, Ontario--(Newsfile Corp. - March 4, 2024) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it has entered into a market making services ag...
Aion Therapeutic Announces Closing of Toppen Health Inc. Acquisition
Toronto, Ontario--(Newsfile Corp. - December 15, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that, further to its press release dated October...
Aion Therapeutic Announces Definitive Agreement to Acquire Toppen Health Inc.
Toronto, Ontario--(Newsfile Corp. - October 23, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that has entered into a definitive share purchase...
Aion Therapeutic Announces Closing of Second Tranche of Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - October 5, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that further to its press released dated September...
Aion Therapeutic Announces Second Tranche of Non-Brokered Private Placement Offering of Units
Toronto, Ontario--(Newsfile Corp. - September 8, 2023) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce that it plans to complete a second tranche of it...
Aion Therapeutic Provides Default Status Update
Toronto, Ontario--(Newsfile Corp. - October 25, 2022) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announces that further to its press releases of September 13, 2022, Sept...
Aion Therapeutic Reports Delay in Filing 2022 Annual Financial Statements
Toronto, Ontario--(Newsfile Corp. - August 18, 2022) - Aion Therapeutic Inc.
Aion Therapeutic Combines the Healing Powers of Cannabinoids and Psychedelics to Treat Cancer and Depression
To date, 74% of prescription drugs are derived from plants, 18% specifically from fungi. Still, many companies hesitate to invest in the medicinal benefits of mushrooms.
Aion Therapeutic's Dr. De La Haye to Speak at the CanEx Psychedelics Summit
TORONTO, July 14, 2021 /PRNewswire/ - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") announced today that Dr. Winston De La Haye, Medical Director of the Aion International Ce...